Literature DB >> 7768998

Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis.

V Mattot1, M B Raes, P Henriet, Y Eeckhout, D Stehelin, B Vandenbunder, X Desbiens.   

Abstract

Collagenases are thought to be involved in physiological and pathological processes that require extracellular matrix remodeling. Using the in situ hybridization technique, we describe the expression of interstitial collagenase gene during mouse embryogenesis between E6.5 and E17. We demonstrate that interstitial collagenase expression is exclusively detected in one event, namely the onset of bone formation. Transcripts accumulate in hypertrophied chondrocytes, found in the mature cartilaginous matrix of long-bone growth plates or ribs, and in osteoblasts and/or in endothelial cells that have migrated into the shafts of developing long bones. The expression of the tissue inhibitor of metalloproteinases (TIMP-2) gene precedes the expression of interstitial collagenase in developing bones. These data suggest that interstitial collagenase plays a specific role in bone development and that the tight regulation of its activity during development is achieved not only by post-translational mechanisms with TIMPs, as previously suggested, but also at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768998     DOI: 10.1242/jcs.108.2.529

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  TGF-beta3-induced palatogenesis requires matrix metalloproteinases.

Authors:  L Blavier; A Lazaryev; J Groffen; N Heisterkamp; Y A DeClerck; V Kaartinen
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Matrix remodeling during endochondral ossification.

Authors:  Nathalie Ortega; Danielle J Behonick; Zena Werb
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

Review 3.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.

Authors:  Christopher B Little; Clare T Meeker; Rosalind M Hembry; Natalie A Sims; Kate E Lawlor; Sue B Golub; Karena Last; Amanda J Fosang
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation.

Authors:  M J Jiménez; M Balbín; J M López; J Alvarez; T Komori; C López-Otín
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  PTHrP overexpression partially inhibits a mechanical strain-induced arthritic phenotype in chondrocytes.

Authors:  D Wang; J M Taboas; R S Tuan
Journal:  Osteoarthritis Cartilage       Date:  2010-11-16       Impact factor: 6.576

7.  VE-statin, an endothelial repressor of smooth muscle cell migration.

Authors:  Fabrice Soncin; Virginie Mattot; Frédéric Lionneton; Nathalie Spruyt; Frédéric Lepretre; Agnès Begue; Dominique Stehelin
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  Prostaglandin F2α receptor (FP) signaling regulates Bmp signaling and promotes chondrocyte differentiation.

Authors:  Joohwee Kim; Minsub Shim
Journal:  Biochim Biophys Acta       Date:  2014-12-11

9.  Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene.

Authors:  Christine E Boumah; Minnkyong Lee; Nagarajan Selvamurugan; Emi Shimizu; Nicola C Partridge
Journal:  Mol Endocrinol       Date:  2009-05-07

10.  Induced GnasR201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling.

Authors:  Sanjoy Kumar Khan; Prem Swaroop Yadav; Gene Elliott; Dorothy Zhang Hu; Ruoshi Xu; Yingzi Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.